These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28235409)

  • 21. Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models.
    Sakamoto T; Ozaki K; Fujio K; Kajikawa SH; Uesato S; Watanabe K; Tanimura S; Koji T; Kohno M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):456-62. PubMed ID: 23501104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity.
    Kaneda D; Iehara T; Kikuchi K; Sugimoto Y; Nakagawa N; Yagyu S; Miyachi M; Konishi E; Sakai T; Hosoi H
    Pediatr Int; 2022 Jan; 64(1):e15159. PubMed ID: 35727889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
    Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo.
    Xu DQ; Toyoda H; Yuan XJ; Qi L; Chelakkot VS; Morimoto M; Hanaki R; Kihira K; Hori H; Komada Y; Hirayama M
    Exp Cell Res; 2018 Apr; 365(2):177-184. PubMed ID: 29499203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
    Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
    Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
    Lamoine S; Cumenal M; Barriere DA; Pereira V; Fereyrolles M; Prival L; Barbier J; Boudieu L; Brasset E; Bertin B; Renaud Y; Miot-Noirault E; Civiale MA; Balayssac D; Aissouni Y; Eschalier A; Busserolles J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
    Islam SS; Mokhtari RB; Akbari P; Hatina J; Yeger H; Farhat WA
    Target Oncol; 2016 Apr; 11(2):209-27. PubMed ID: 26453055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
    Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
    Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
    Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.
    Gu S; Tian Y; Chlenski A; Salwen HR; Lu Z; Raj JU; Yang Q
    Anticancer Drugs; 2012 Nov; 23(10):1054-66. PubMed ID: 22863973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies.
    Singh A; Meier-Stephenson V; Jayanthan A; Narendran A
    Curr Cancer Drug Targets; 2017; 17(6):569-584. PubMed ID: 27875952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14.
    Ding X; Xiang L; Wang N; Zhao Z; Jin X; Sun Y; Duan W; Wang S; Jin X
    Oncol Rep; 2014 Mar; 31(3):1165-74. PubMed ID: 24399074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
    Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
    BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
    Tanos R; Karmali D; Nalluri S; Goldsmith KC
    BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
    Frys S; Simons Z; Hu Q; Barth MJ; Gu JJ; Mavis C; Skitzki J; Song L; Czuczman MS; Hernandez-Ilizaliturri FJ
    Br J Haematol; 2015 May; 169(4):506-19. PubMed ID: 25712263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane.
    Bayat Mokhtari R; Baluch N; Morgatskaya E; Kumar S; Sparaneo A; Muscarella LA; Zhao S; Cheng HL; Das B; Yeger H
    BMC Cancer; 2019 Aug; 19(1):864. PubMed ID: 31470802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
    Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
    J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
    Zhao B; He T
    Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts.
    Karmakar S; Choudhury SR; Banik NL; Ray SK
    Neuroscience; 2009 Sep; 163(1):286-95. PubMed ID: 19540315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.